Quest Diagnostics Incorporated (NYSE:DGX):
Quest Diagnostics To Host Investor Day On November 11, 2016.
The company is so far trading up from yesterday’s close of $84.6.
Additionally Quest Diagnostics Incorporated recently declared a dividend to be paid on Wednesday the 19th of October 2016. The dividend will be $0.400 per share for the quarter which comes to $1.60 on an annualized basis. The dividend yield will be $1.87. The ex-dividend date is Friday the 1st of July 2016.
Company chares are trading at $84.77 which is just over $84.04, the 50 day moving average and slightly over the 200 day moving average of $78.94. The 50 day moving average went up by +0.84% whereas the 200 day average was up by +7.34%.
The company’s P/E ratio is 14.79 and the market cap is 11.78B. In the latest earnings report the EPS was $5.73 and is projected to be $5.11 for the current year with 139,016,000 shares outstanding. Analysts expect next quarter’s EPS to be $1.29 with next year’s EPS projected to be $5.45.
Ratings analysts have provided guidance on Quest Diagnostics Incorporated . On August 31, 2016 the stock rating was set at “Neutral” in a report from Mizuho Securities a cut from the previous “Buy” rating. On June 24 the company was downgraded to “” from “” by Jyske Bank.
On March 15 analysts at Credit Suisse starting coverage on DGX by announcing an initial rating of “Neutral” and projecting a price target of $72.00. Equity analyst Mizuho Securities upgraded the stock and raised the price target on March 1 changing the price target from $0.00 to $75.00 and changing the rating from “Neutral” to “Buy”.
On March 1 the stock rating was upgraded from “Neutral” to “Buy” and a price target of $75.00 was set in a report issued by Mizuho Securities. On October 23 Barclays made no change to the stock rating of “Equalweight” but lowered the price expectation to $72.00 from $78.00.